Stocks to buy today: GAIL, Dixon Technologies among top 4 trading ideas for 20 May 2025
Indian market anticipates a positive trading session on Tuesday. This is due to encouraging global signals. Nifty futures saw a dip on Monday. Volatility increased as India VIX rose. Option data suggests a trading range. Experts recommend buying Divi’s Laboratories, Dixon Technologies, GAIL India, and ICICI Prudential Life. Foreign and domestic institutional investors showed caution […]
Borana Weaves IPO opens for subscription with healthy GMP. Should you bid?
Borana Weaves, a Surat-based textile manufacturer, launched its IPO today, aiming to raise approximately Rs 145 crore through a fresh issue of shares. The IPO, priced between Rs 205 and Rs 216 per share, will fund a new manufacturing unit and working capital.
Financials remain the backbone; cement, chemicals emerge as new leaders: Nischal Maheshwari
Market expert Nischal Maheshwari suggests a consolidation phase after a strong run. He anticipates a potential new high in the current fiscal year. Financials are expected to continue performing well. Cement shows strong volume growth and price improvement. The US market is also expected to grow. Chemical sector is poised for a strong comeback.
Golden Crossovers: These 3 stocks signal bullishness on May 20
In the NSE list of stocks, three stocks with a market cap of over Rs 1000 crore are witnessing Golden Crossovers, according to stockedge.com’s technical scan data.
Financials still in play, but rotation towards quality largecaps underway: Jigar Mistry
Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.
Q4 results today: Hindalco among 145 companies to announce earnings on Tuesday
Hindalco Industries is expected to announce its Q4FY25 earnings, with brokerages predicting a net profit growth between 25% and 55%. Revenue could rise by 4% to 12%, driven by higher aluminium and alumina prices. Axis Securities anticipates a strong performance, with a 29% YoY increase in PAT and a 12% YoY growth in revenue.
How will higher anchor investor allocation impact lower rated bond market?
The capital markets regulator has introduced a credit-rating based quota for allocating limits for anchor investors, according to a circular issued on Friday. Earlier, the anchor allocation was capped at 30% of the base size.
RBI accepts lower bond purchase amount in first FY26 OMO auction
RBI accepted bids worth ₹19,203 crore at this OMO, lower compared to the notified amount of ₹25,000 crore. RBI had received bids worth ₹50,369 crore. This is first FY26 OMO auction where RBI accepted a lower amount.
DRL gears up for biosimilar push, consumer health growth post record FY25
Dr Reddy’s stock rose 5.5% in six sessions post-Q4 results, outperforming the BSE Healthcare index. Strong revenue growth, biosimilar launches, and semaglutide portfolio support long-term prospects despite Revlimid taper and reduced target prices by analysts.
Asian stocks advance after rebound on Wall Street
India is discussing a US trade deal structured in three tranches and expects to reach an interim agreement before July, when President Donald Trump’s reciprocal tariffs are set to kick in, according to officials in New Delhi familiar with the matter.